| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-10 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-09 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-08 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
8e-08 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-08 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-07 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |